Javier Benítez Ortiz-rekin lankidetzan egindako argitalpenak (2)

2011

  1. Effect of ABCB1 and ABCC3 polymorphisms on osteosarcoma survival after chemotherapy: A pharmacogenetic study

    PLoS ONE, Vol. 6, Núm. 10

2009

  1. Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients

    Pharmacogenomics Journal, Vol. 9, Núm. 5, pp. 347-353